Spybiotech

Developer of vaccines for bacterial infections and cancer by using proprietary protein superglue technology

placeOxford, England, United Kingdom calendar_todayFounded 2017 groups10 employees language spybiotech.com

Innovation

10 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating.

Social engagement

Social engagement: 2.7K social following, 8 posts in the last 12 months — below the industry typical range.

Recent activity

7 Jan 2026
Event
J.P. Morgan Healthcare Conference 2026
10 Dec 2025
Partnership
Oxford Science Enterprises
3 Sep 2025
Event
Congenital Cytomegalovirus Public Health & Policy Conference
Coming soon